Back to search

Article

The structural basis for LRRK2’s activation and autoinhibition

2026-06-03

Abstract excerpt

<h4>SUMMARY</h4> Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are the second most common cause of autosomal-dominant Parkinson’s disease (PD), and increased LRRK2 kinase activity is also observed in idiopathic PD, making LRRK2 a major actionable therapeutic target. LRRK2 is a 286-kDa multidomain enzyme containing a Ras-like GTPase (ROC) and a kinase domain. Using cryo-EM, biochemical reconstitution, and cell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2e4f346-b2e1-56b9-9a70-155f6e606beb
DOI
10.64898/2026.05.31.729085
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The structural basis for LRRK2’s activation and autoinhibitionDOI 10.64898/2026.05.31.729085
Select a neighboring publication to make it the new centre.